Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PARIS & COPENHAGEN--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO), an innovative company specialized in the development of orphan...
-
Preclinical Research Published in Clinical Cancer Research PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO)...
-
Expansion of orphan oncology pipeline through acquisition of DNA Therapeutics and lead compound AsiDNATM Important development milestones on existing assets: · Livatag® Phase III trial in HCC: 80%...
-
•Agreement covering seven South American countries •Onxeo to receive upfront payment, regulatory and commercial milestones, and sales royalties for a total deal value greater than USD 20 million PARIS...
-
PARIS, Frankrig & KØBENHAVN, Danmark--(BUSINESS WIRE (http://www.businesswire.com/))-- Fondsbørsmeddelelse: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), et innovativt selskab med speciale i...
-
PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative...
-
· Products, including AsiDNA (signal interfering DNA), protected until 2031 with potential extension to 2036 · Onxeo’s intellectual property for DNA repair signal interfering technology and products...
-
· Produkter, herunder AsiDNA (signal-interfererende DNA), beskyttet indtil 2031 med mulig forlængelse til 2036 · Onxeos immaterielle rettigheder for DNA-reparations signal-interfererende teknologi...
-
Forventelige milepæle på kort og langt sigt PARIS & KØBENHAVN, Danmark--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris,...
-
Near- and mid term expected milestones PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris,...